Literature DB >> 23612789

Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.

Weimin C Hong1, Susan G Amara.   

Abstract

The dopamine transporter (DAT) clears the extracellular dopamine released during neurotransmission and is a major target for both therapeutic and addictive psychostimulant amphetamines. Amphetamine exposure or activation of protein kinase C (PKC) by the phorbol ester PMA has been shown to down-regulate cell surface DAT. However, in dopamine neurons, the trafficking itinerary and fate of internalized DAT has not been elucidated. By monitoring surface-labeled DAT in transfected dopamine neurons from embryonic rat mesencephalic cultures, we find distinct sorting and fates of internalized DAT after amphetamine or PMA treatment. Although both drugs promote DAT internalization above constitutive endocytosis in dopamine neurons, PMA induces ubiquitination of DAT and leads to accumulation of DAT on LAMP1-positive endosomes. In contrast, after amphetamine exposure DAT is sorted to recycling endosomes positive for Rab11 and the transferrin receptor. Furthermore, quantitative assessment of DAT recycling using an antibody-feeding assay reveals that significantly less DAT returns to the surface of dopamine neurons after internalization by PMA, compared with vehicle or amphetamine treatment. These results demonstrate that, in neurons, the DAT is sorted differentially to recycling and degradative pathways after psychostimulant exposure or PKC activation, which may allow for either the transient or sustained inhibition of DAT during dopamine neurotransmission.

Entities:  

Keywords:  endosome sorting; fluorescence imaging; internalization; ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 23612789      PMCID: PMC3714572          DOI: 10.1096/fj.12-218727

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals.

Authors:  Derek B Scott; Ioannis Michailidis; Yuanyue Mu; Diomedes Logothetis; Michael D Ehlers
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

2.  Recycling endosomes supply AMPA receptors for LTP.

Authors:  Mikyoung Park; Esther C Penick; Jeffrey G Edwards; Julie A Kauer; Michael D Ehlers
Journal:  Science       Date:  2004-09-24       Impact factor: 47.728

3.  Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors.

Authors:  Yoko Sekine-Aizawa; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

4.  Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.

Authors:  S J Zhu; M P Kavanaugh; M S Sonders; S G Amara; N R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

5.  Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices.

Authors:  L Kantor; M E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

6.  Membrane trafficking regulates the activity of the human dopamine transporter.

Authors:  H E Melikian; K M Buckley
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

7.  Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons.

Authors:  Jacob Eriksen; Walden Emil Bjørn-Yoshimoto; Trine Nygaard Jørgensen; Amy Hauck Newman; Ulrik Gether
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

8.  Rapid and reversible effects of methamphetamine on dopamine transporters.

Authors:  A E Fleckenstein; R R Metzger; D G Wilkins; J W Gibb; G R Hanson
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

9.  Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.

Authors:  José A Morón; Irina Zakharova; Jasmine V Ferrer; Gerald A Merrill; Bruce Hope; Eileen M Lafer; Zhi Cheng Lin; Jia Bei Wang; Jonathan A Javitch; Aurelio Galli; Toni S Shippenberg
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

10.  Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment.

Authors:  I Mellman; H Plutner; P Ukkonen
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  27 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

2.  Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.

Authors:  Luke R Gabriel; Sijia Wu; Patrick Kearney; Karl D Bellvé; Clive Standley; Kevin E Fogarty; Haley E Melikian
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

3.  The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.

Authors:  Daniel P Bermingham; J Andrew Hardaway; Osama Refai; Christian R Marks; Sam L Snider; Sarah M Sturgeon; William C Spencer; Roger J Colbran; David M Miller; Randy D Blakely
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

4.  The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.

Authors:  Sijia Wu; Rita R Fagan; Chayasith Uttamapinant; Lawrence M Lifshitz; Kevin E Fogarty; Alice Y Ting; Haley E Melikian
Journal:  J Neurosci       Date:  2017-08-28       Impact factor: 6.167

5.  A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.

Authors:  Mark J Ferris; Erin S Calipari; Jamie H Rose; Cody A Siciliano; Haiguo Sun; Rong Chen; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2015-02-18       Impact factor: 7.853

6.  Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact.

Authors:  Rita R Fagan; Patrick J Kearney; Carolyn G Sweeney; Dino Luethi; Florianne E Schoot Uiterkamp; Klaus Schicker; Brian S Alejandro; Lauren C O'Connor; Harald H Sitte; Haley E Melikian
Journal:  J Biol Chem       Date:  2020-03-04       Impact factor: 5.157

7.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

Review 8.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

9.  Clustered Kv2.1 decreases dopamine transporter activity and internalization.

Authors:  Joseph J Lebowitz; Jose A Pino; Phillip M Mackie; Min Lin; Cheyenne Hurst; Keeley Divita; Anthony T Collins; Dimitri N Koutzoumis; Gonzalo E Torres; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

Review 10.  Mechanisms of dopamine transporter regulation in normal and disease states.

Authors:  Roxanne A Vaughan; James D Foster
Journal:  Trends Pharmacol Sci       Date:  2013-08-20       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.